Breast cancer chemoprevention pharmacogenomics: Deep sequencing and functional genomics of the ZNF423 and CTSO genes

Our previous GWAS using samples from the NSABP P-1 and P-2 selective estrogen receptor modulator (SERM) breast cancer prevention trials identified SNPs in ZNF423 and near CTSO that were associated with breast cancer risk during SERM chemoprevention. We have now performed Next Generation DNA sequenci...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:NPJ Breast Cancer
Asıl Yazarlar: Liu, Duan, Ho, Ming-Fen, Schaid, Daniel J., Scherer, Steven E., Kalari, Krishna, Liu, Mohan, Biernacka, Joanna, Yee, Vivien, Evans, Jared, Carlson, Erin, Goetz, Matthew P., Kubo, Michiaki, Wickerham, D. Lawrence, Wang, Liewei, Ingle, James N., Weinshilboum, Richard M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group UK 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5566425/
https://ncbi.nlm.nih.gov/pubmed/28856246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-017-0036-4
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller